publication date: Dec. 16, 2011
Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages are Created Equal caBIG Architect Kenneth Buetow Resigns Anil Potti Explains: “Coming from India, I Did Not Know This Was Not The Real Rhodes Scholarship” Download PDF
The Cancer Letter will take a holiday break. Next issue: Jan. 6.
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.